LYKALABS Buy Hold or Sell Recommendation

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>LL</div>
LYKALABS -- India Stock  

INR 20.00  0.10  0.50%

Assuming the 30 trading days horizon, and your above-average risk tolerance our recommendation regarding LYKA LABORATORIES is 'Strong Sell'. Macroaxis provides LYKA LABORATORIES buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding LYKALABS positions. The advice algorithm takes into account all of LYKA LABORATORIES available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from LYKALABS buy-and-hold perspective. Additionally, see LYKA LABORATORIES Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments please use Instant Ratings tool.

Search Advice

 
Refresh

Time Horizon

Risk Tolerance

Execute Advice
Sell LYKA LABORATORIESBuy LYKA LABORATORIES
Strong Sell

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Not Available
For the selected time horizon LYKA LABORATORIES has a mean deviation of 3.93, semi deviation of 3.28, standard deviation of 5.62, variance of 31.59, downside variance of 17.54 and semi variance of 10.79
Our advice module can be used to complement current analysts and expert consensus on LYKA LABORATORIES. Our buy or sell recommendations engine harnesses analyzes the company potential to grow using all fundamental data market data available at this particular time. To make sure LYKA LABORATORIES is not overpriced, please verify all LYKA LABORATORIES fundamentals, including its net income, and the relationship between the price to sales and debt to equity .

LYKA LABORATORIES Trading Alerts and Improvement Suggestions

LYKA LABORATORIES has very high historical volatility over the last 30 days
LYKA LABORATORIES has high likelihood to experience some financial distress in the next 2 years
The company has accumulated 1.41 B in total debt with debt to equity ratio (D/E) of 2.33, implying the company greatly relies on financing operations through barrowing. LYKA LABORATORIES has a current ratio of 0.53, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
The entity reported revenue of 645.05 M. Net Loss for the year was (605.34 M) with profit before overhead, payroll, taxes, and interest of 287.11 M.
About 48.0% of LYKA LABORATORIES outstanding shares are owned by corporate insiders

LYKA LABORATORIES Returns Distribution Density

The chart of the probability distribution of LYKA LABORATORIES stock daily returns describes the distribution of returns around its average expected value. We use LYKA LABORATORIES' stock's Value At Risk and its Upside Potential as a relative measure of the distribution. The distribution of LYKA LABORATORIES returns is essential to provide solid investment advice for LYKA LABORATORIES stock.
Mean Return0.93Value At Risk-7.11
Potential Upside10.76Standard Deviation5.62
 Return Density 
      Distribution 
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of LYKA LABORATORIES historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

LYKA LABORATORIES Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to LYKA LABORATORIES or LYKA LABORATORIES sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that LYKA LABORATORIES stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a LYKALABS stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over DOW
=1.01
β
Beta against DOW=-0.6
σ
Overall volatility
=4.82
Ir
Information ratio =0.13

LYKA LABORATORIES Volatility Alert

LYKA LABORATORIES shows above-average downside volatility of 4.19 for the selected time horizon. We advise investors to inspect LYKA LABORATORIES further and to ensure all market timing and asset allocation strategies are consistent with estimation about LYKA LABORATORIES future alpha.
    
 Better Than Average     
    
 Worse Than Average Compare LYKA LABORATORIES to competition

LYKA LABORATORIES Fundamental Vs Peers

FundamentalsLYKA LABORATORIESPeer Average
Return On Equity(408.61) %(0.31) %
Return On Asset(2.57) %(0.14) %
Profit Margin(93.85) %(1.27) %
Operating Margin(13.32) %(5.51) %
Current Valuation1.76 B16.62 B
Shares Outstanding28.69 M571.82 M
Shares Owned by Insiders48.10 %10.09 %
Price to Earning(22.00) X28.72 X
Price to Book1.26 X9.51 X
Price to Sales0.98 X11.42 X
Revenue645.05 M9.43 B
Gross Profit287.11 M27.38 B
EBITDA(5.8 M)3.9 B
Net Income(605.34 M)570.98 M
Cash and Equivalents119.19 M2.7 B
Cash per Share5.49 X5.01 X
Total Debt1.41 B5.32 B
Debt to Equity2.33 %48.70 %
Current Ratio0.54 X2.16 X
Book Value Per Share(6.60) X1.93 K
Cash Flow from Operations53.23 M971.22 M
Earnings Per Share(21.29) X3.12 X
Number of Employees418.84 K
Beta1.26-0.15
Market Capitalization634.12 M19.03 B

About LYKA LABORATORIES Buy or Sell Advice

When is the right time to buy or sell LYKA LABORATORIES? Buying stocks such as LYKA LABORATORIES isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily bases. Although LYKA LABORATORIES investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply. Please read more on our stock advisor page.

Did You Try This Idea?

Run Utilities Thematic Idea Now

Utilities
Utilities Theme
Highly leveraged corporations that deliver utilities such as power, water or gas to public or business. Utilities theme has 30 constituents.
View All  Next Launch Utilities
Additionally, see LYKA LABORATORIES Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments please use Instant Ratings tool. Please also try Global Correlations module to find global opportunities by holding instruments from different markets.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page